Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | DGX | Common Stock | Award | $381K | +2.58K | +24.41% | $147.86 | 13.1K | Mar 6, 2023 | Direct | F1 |
transaction | DGX | Common Stock | Tax liability | -$118K | -799 | -6.07% | $147.86 | 12.4K | Mar 6, 2023 | Direct | F2, F3 |
Id | Content |
---|---|
F1 | Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 18, 2020, approved in accordance with the requirements of Rule 16b-3(d). |
F2 | Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. |
F3 | The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. |